Report Detail

Pharma & Healthcare Global TB Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4592443
  • |
  • 05 June, 2024
  • |
  • Global
  • |
  • 105 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global TB Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the TB Vaccines industry chain, the market status of Hospitals (Immunotherapeutic Vaccines, Booster Vaccines), Private Clinics (Immunotherapeutic Vaccines, Booster Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of TB Vaccines.
Regionally, the report analyzes the TB Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global TB Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the TB Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the TB Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Immunotherapeutic Vaccines, Booster Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the TB Vaccines market.
Regional Analysis: The report involves examining the TB Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the TB Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to TB Vaccines:
Company Analysis: Report covers individual TB Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards TB Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Private Clinics).
Technology Analysis: Report covers specific technologies relevant to TB Vaccines. It assesses the current state, advancements, and potential future developments in TB Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the TB Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
TB Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Market segment by Application
Hospitals
Private Clinics
Research Institutes
Major players covered
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe TB Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of TB Vaccines, with price, sales, revenue and global market share of TB Vaccines from 2019 to 2024.
Chapter 3, the TB Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TB Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and TB Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of TB Vaccines.
Chapter 14 and 15, to describe TB Vaccines sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of TB Vaccines
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global TB Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Immunotherapeutic Vaccines
    • 1.3.3 Booster Vaccines
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global TB Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Private Clinics
    • 1.4.4 Research Institutes
  • 1.5 Global TB Vaccines Market Size & Forecast
    • 1.5.1 Global TB Vaccines Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global TB Vaccines Sales Quantity (2019-2030)
    • 1.5.3 Global TB Vaccines Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Merck & Co.,Inc
    • 2.1.1 Merck & Co.,Inc Details
    • 2.1.2 Merck & Co.,Inc Major Business
    • 2.1.3 Merck & Co.,Inc TB Vaccines Product and Services
    • 2.1.4 Merck & Co.,Inc TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Merck & Co.,Inc Recent Developments/Updates
  • 2.2 Sanofi Pasteur
    • 2.2.1 Sanofi Pasteur Details
    • 2.2.2 Sanofi Pasteur Major Business
    • 2.2.3 Sanofi Pasteur TB Vaccines Product and Services
    • 2.2.4 Sanofi Pasteur TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Sanofi Pasteur Recent Developments/Updates
  • 2.3 Japan BCG Laboratory
    • 2.3.1 Japan BCG Laboratory Details
    • 2.3.2 Japan BCG Laboratory Major Business
    • 2.3.3 Japan BCG Laboratory TB Vaccines Product and Services
    • 2.3.4 Japan BCG Laboratory TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Japan BCG Laboratory Recent Developments/Updates
  • 2.4 China National Biotec Group
    • 2.4.1 China National Biotec Group Details
    • 2.4.2 China National Biotec Group Major Business
    • 2.4.3 China National Biotec Group TB Vaccines Product and Services
    • 2.4.4 China National Biotec Group TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 China National Biotec Group Recent Developments/Updates
  • 2.5 Serum Institute
    • 2.5.1 Serum Institute Details
    • 2.5.2 Serum Institute Major Business
    • 2.5.3 Serum Institute TB Vaccines Product and Services
    • 2.5.4 Serum Institute TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Serum Institute Recent Developments/Updates
  • 2.6 India Pvt. Ltd
    • 2.6.1 India Pvt. Ltd Details
    • 2.6.2 India Pvt. Ltd Major Business
    • 2.6.3 India Pvt. Ltd TB Vaccines Product and Services
    • 2.6.4 India Pvt. Ltd TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 India Pvt. Ltd Recent Developments/Updates
  • 2.7 InterVax Ltd
    • 2.7.1 InterVax Ltd Details
    • 2.7.2 InterVax Ltd Major Business
    • 2.7.3 InterVax Ltd TB Vaccines Product and Services
    • 2.7.4 InterVax Ltd TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 InterVax Ltd Recent Developments/Updates
  • 2.8 GreenSignal
    • 2.8.1 GreenSignal Details
    • 2.8.2 GreenSignal Major Business
    • 2.8.3 GreenSignal TB Vaccines Product and Services
    • 2.8.4 GreenSignal TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 GreenSignal Recent Developments/Updates
  • 2.9 Bio Pharma Limited
    • 2.9.1 Bio Pharma Limited Details
    • 2.9.2 Bio Pharma Limited Major Business
    • 2.9.3 Bio Pharma Limited TB Vaccines Product and Services
    • 2.9.4 Bio Pharma Limited TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bio Pharma Limited Recent Developments/Updates
  • 2.10 Statens Serum Institut
    • 2.10.1 Statens Serum Institut Details
    • 2.10.2 Statens Serum Institut Major Business
    • 2.10.3 Statens Serum Institut TB Vaccines Product and Services
    • 2.10.4 Statens Serum Institut TB Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Statens Serum Institut Recent Developments/Updates

3 Competitive Environment: TB Vaccines by Manufacturer

  • 3.1 Global TB Vaccines Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global TB Vaccines Revenue by Manufacturer (2019-2024)
  • 3.3 Global TB Vaccines Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of TB Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 TB Vaccines Manufacturer Market Share in 2023
    • 3.4.2 Top 6 TB Vaccines Manufacturer Market Share in 2023
  • 3.5 TB Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 TB Vaccines Market: Region Footprint
    • 3.5.2 TB Vaccines Market: Company Product Type Footprint
    • 3.5.3 TB Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global TB Vaccines Market Size by Region
    • 4.1.1 Global TB Vaccines Sales Quantity by Region (2019-2030)
    • 4.1.2 Global TB Vaccines Consumption Value by Region (2019-2030)
    • 4.1.3 Global TB Vaccines Average Price by Region (2019-2030)
  • 4.2 North America TB Vaccines Consumption Value (2019-2030)
  • 4.3 Europe TB Vaccines Consumption Value (2019-2030)
  • 4.4 Asia-Pacific TB Vaccines Consumption Value (2019-2030)
  • 4.5 South America TB Vaccines Consumption Value (2019-2030)
  • 4.6 Middle East and Africa TB Vaccines Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global TB Vaccines Sales Quantity by Type (2019-2030)
  • 5.2 Global TB Vaccines Consumption Value by Type (2019-2030)
  • 5.3 Global TB Vaccines Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global TB Vaccines Sales Quantity by Application (2019-2030)
  • 6.2 Global TB Vaccines Consumption Value by Application (2019-2030)
  • 6.3 Global TB Vaccines Average Price by Application (2019-2030)

7 North America

  • 7.1 North America TB Vaccines Sales Quantity by Type (2019-2030)
  • 7.2 North America TB Vaccines Sales Quantity by Application (2019-2030)
  • 7.3 North America TB Vaccines Market Size by Country
    • 7.3.1 North America TB Vaccines Sales Quantity by Country (2019-2030)
    • 7.3.2 North America TB Vaccines Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe TB Vaccines Sales Quantity by Type (2019-2030)
  • 8.2 Europe TB Vaccines Sales Quantity by Application (2019-2030)
  • 8.3 Europe TB Vaccines Market Size by Country
    • 8.3.1 Europe TB Vaccines Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe TB Vaccines Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific TB Vaccines Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific TB Vaccines Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific TB Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific TB Vaccines Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific TB Vaccines Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America TB Vaccines Sales Quantity by Type (2019-2030)
  • 10.2 South America TB Vaccines Sales Quantity by Application (2019-2030)
  • 10.3 South America TB Vaccines Market Size by Country
    • 10.3.1 South America TB Vaccines Sales Quantity by Country (2019-2030)
    • 10.3.2 South America TB Vaccines Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa TB Vaccines Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa TB Vaccines Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa TB Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa TB Vaccines Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa TB Vaccines Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 TB Vaccines Market Drivers
  • 12.2 TB Vaccines Market Restraints
  • 12.3 TB Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of TB Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of TB Vaccines
  • 13.3 TB Vaccines Production Process
  • 13.4 TB Vaccines Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 TB Vaccines Typical Distributors
  • 14.3 TB Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on TB Vaccines. Industry analysis & Market Report on TB Vaccines is a syndicated market report, published as Global TB Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of TB Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,756.16
    4,134.24
    5,512.32
    3,253.80
    4,880.70
    6,507.60
    556,243.20
    834,364.80
    1,112,486.40
    290,962.80
    436,444.20
    581,925.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report